BR9916288A - Clatratos de deidroepiandroesterona e correspondentes composições farmacêuticas - Google Patents
Clatratos de deidroepiandroesterona e correspondentes composições farmacêuticasInfo
- Publication number
- BR9916288A BR9916288A BR9916288-1A BR9916288A BR9916288A BR 9916288 A BR9916288 A BR 9916288A BR 9916288 A BR9916288 A BR 9916288A BR 9916288 A BR9916288 A BR 9916288A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- clathrates
- dehydroepianderesterone
- corresponding pharmaceutical
- dehydropianderesterone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
<B>"CLATRATOS DE DEIDROEPIANDROESTERONA E CORRESPONDENTES COMPOSIçõES FARMACêUTICAS"<D> A presente invenção se refere a clatrados de deidropiandroesterona, possivelmente na forma de sulfato, em uma matriz consistindo de uma ciclodextrina e opcionalmente compreendendo um agente de co-solubilização e às correspondentes composições farmacêuticas adequadas para terapia de substituição, para o tratamento de insuficiência adrenocortical.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002745A IT1304190B1 (it) | 1998-12-18 | 1998-12-18 | Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche |
PCT/EP1999/010010 WO2000037109A2 (en) | 1998-12-18 | 1999-12-16 | Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916288A true BR9916288A (pt) | 2001-10-16 |
Family
ID=11381280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916288-1A BR9916288A (pt) | 1998-12-18 | 1999-12-16 | Clatratos de deidroepiandroesterona e correspondentes composições farmacêuticas |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1140110B1 (pt) |
JP (1) | JP2002532565A (pt) |
KR (1) | KR100693514B1 (pt) |
CN (1) | CN1198620C (pt) |
AR (1) | AR021663A1 (pt) |
AT (1) | ATE243517T1 (pt) |
AU (1) | AU759979B2 (pt) |
BR (1) | BR9916288A (pt) |
CA (1) | CA2355148A1 (pt) |
CO (1) | CO5231137A1 (pt) |
DE (1) | DE69909128T2 (pt) |
DK (1) | DK1140110T3 (pt) |
EA (1) | EA003304B1 (pt) |
ES (1) | ES2203232T3 (pt) |
HU (1) | HU225414B1 (pt) |
IL (2) | IL143776A0 (pt) |
IT (1) | IT1304190B1 (pt) |
NZ (1) | NZ512795A (pt) |
PE (1) | PE20001379A1 (pt) |
PT (1) | PT1140110E (pt) |
TR (1) | TR200101766T2 (pt) |
TW (1) | TWI225791B (pt) |
WO (1) | WO2000037109A2 (pt) |
ZA (1) | ZA200105223B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2815860B1 (fr) * | 2000-10-26 | 2003-12-12 | Oreal | Composition, notamment cosmetique, comprenant la dhea et/ou precurseur ou derive de celle-ci et au moins un agent myorelaxant |
EP1285927A3 (de) * | 2001-08-16 | 2005-06-29 | Schering Aktiengesellschaft | Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems |
ITMI20021074A1 (it) * | 2002-05-20 | 2003-11-20 | Actimex S R L | Composizione ternaria comprendente una sostanza attiva e processo di comacinazione per la sua preparazione |
ITMI20022549A1 (it) * | 2002-12-02 | 2004-06-03 | Actimex S R L | Composizione quaternaria comprendente come sostanza attiva la propolis. |
US20070191404A1 (en) | 2004-04-01 | 2007-08-16 | Pierre Bartsch | Pharmaceutical compositions of pyrimidine-2,4,6-triones |
WO2006137433A1 (ja) * | 2005-06-21 | 2006-12-28 | Wakamoto Pharmaceutical Co., Ltd. | レボカバスチンを可溶化させた水性薬剤 |
ITPD20050224A1 (it) * | 2005-07-19 | 2007-01-20 | Actimex Srl | Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego |
US8268806B2 (en) * | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
ES2545337T3 (es) * | 2011-07-19 | 2015-09-10 | Pantarhei Bioscience B.V. | Comprimido que contiene dehidroepiandrosterona (DHEA) |
DE102012101680A1 (de) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat |
EP2986634B1 (en) * | 2013-04-19 | 2019-11-20 | University of Houston System | Cocrystalline dhea formulations |
EP3505154B1 (en) | 2017-12-26 | 2022-04-06 | Industrial Technology Research Institute | Composition for improving the solubility of poorly soluble substances, use thereof and complex formulation containing thereof |
EP3666260A1 (en) | 2018-12-13 | 2020-06-17 | Laboratorios Leon Farma SA | Ethinyl estradiol-beta-cyclodextrin complex and process for preparing thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
US4978532A (en) * | 1989-08-11 | 1990-12-18 | Pharmedic Co. | Dosage form for administration of dehydroepiandrosterone |
US5120720A (en) * | 1990-09-20 | 1992-06-09 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers |
WO1994004155A1 (en) * | 1992-08-19 | 1994-03-03 | Health Resource Institute, Ltd. | Dehydroepiandrosterone therapy for the treatment of eye disorders |
WO1995015746A1 (en) * | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Liposome delivery systems |
CN1201397A (zh) * | 1995-11-13 | 1998-12-09 | 萨珀根公司 | 甾族化合物给药的改进配方 |
-
1998
- 1998-12-18 IT IT1998MI002745A patent/IT1304190B1/it active
-
1999
- 1999-12-14 AR ARP990106362A patent/AR021663A1/es not_active Application Discontinuation
- 1999-12-14 CO CO99077980A patent/CO5231137A1/es not_active Application Discontinuation
- 1999-12-14 TW TW088121876A patent/TWI225791B/zh not_active IP Right Cessation
- 1999-12-16 WO PCT/EP1999/010010 patent/WO2000037109A2/en active IP Right Grant
- 1999-12-16 CN CNB998157716A patent/CN1198620C/zh not_active Expired - Fee Related
- 1999-12-16 AT AT99963559T patent/ATE243517T1/de not_active IP Right Cessation
- 1999-12-16 KR KR1020017007454A patent/KR100693514B1/ko not_active IP Right Cessation
- 1999-12-16 DK DK99963559T patent/DK1140110T3/da active
- 1999-12-16 DE DE69909128T patent/DE69909128T2/de not_active Expired - Fee Related
- 1999-12-16 BR BR9916288-1A patent/BR9916288A/pt not_active IP Right Cessation
- 1999-12-16 TR TR2001/01766T patent/TR200101766T2/xx unknown
- 1999-12-16 AU AU19810/00A patent/AU759979B2/en not_active Ceased
- 1999-12-16 ES ES99963559T patent/ES2203232T3/es not_active Expired - Lifetime
- 1999-12-16 HU HU0104822A patent/HU225414B1/hu not_active IP Right Cessation
- 1999-12-16 EA EA200100674A patent/EA003304B1/ru not_active IP Right Cessation
- 1999-12-16 PT PT99963559T patent/PT1140110E/pt unknown
- 1999-12-16 IL IL14377699A patent/IL143776A0/xx not_active IP Right Cessation
- 1999-12-16 PE PE1999001262A patent/PE20001379A1/es not_active Application Discontinuation
- 1999-12-16 JP JP2000589219A patent/JP2002532565A/ja active Pending
- 1999-12-16 EP EP99963559A patent/EP1140110B1/en not_active Expired - Lifetime
- 1999-12-16 NZ NZ512795A patent/NZ512795A/en unknown
- 1999-12-16 CA CA002355148A patent/CA2355148A1/en not_active Abandoned
-
2001
- 2001-06-14 IL IL143776A patent/IL143776A/en unknown
- 2001-06-25 ZA ZA200105223A patent/ZA200105223B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000037109A3 (en) | 2000-09-14 |
PT1140110E (pt) | 2003-11-28 |
ITMI982745A1 (it) | 2000-06-18 |
AU1981000A (en) | 2000-07-12 |
TWI225791B (en) | 2005-01-01 |
ZA200105223B (en) | 2002-09-25 |
IT1304190B1 (it) | 2001-03-08 |
DE69909128T2 (de) | 2004-05-06 |
DK1140110T3 (da) | 2003-10-20 |
TR200101766T2 (tr) | 2001-12-21 |
ES2203232T3 (es) | 2004-04-01 |
CN1333686A (zh) | 2002-01-30 |
HU225414B1 (en) | 2006-11-28 |
AR021663A1 (es) | 2002-07-31 |
NZ512795A (en) | 2003-08-29 |
IL143776A (en) | 2007-03-08 |
WO2000037109A2 (en) | 2000-06-29 |
HUP0104822A2 (hu) | 2002-05-29 |
KR20010086109A (ko) | 2001-09-07 |
CO5231137A1 (es) | 2002-12-27 |
CA2355148A1 (en) | 2000-06-29 |
EA200100674A1 (ru) | 2001-12-24 |
IL143776A0 (en) | 2002-04-21 |
EP1140110B1 (en) | 2003-06-25 |
AU759979B2 (en) | 2003-05-01 |
CN1198620C (zh) | 2005-04-27 |
PE20001379A1 (es) | 2000-11-25 |
EP1140110A2 (en) | 2001-10-10 |
HUP0104822A3 (en) | 2002-08-28 |
JP2002532565A (ja) | 2002-10-02 |
ATE243517T1 (de) | 2003-07-15 |
DE69909128D1 (de) | 2003-07-31 |
KR100693514B1 (ko) | 2007-03-14 |
EA003304B1 (ru) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9916288A (pt) | Clatratos de deidroepiandroesterona e correspondentes composições farmacêuticas | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
ES2162319T3 (es) | Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer. | |
BR0109131A (pt) | Fator viii modificado | |
BRPI0515684A (pt) | formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas | |
BR0113184A (pt) | Implante artificial e processo para produzir o mesmo | |
DE69636989D1 (de) | Bioaktive lasttragende zusammensetzungen zum knochenverbund | |
BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
GB0108592D0 (en) | Therapeutic agents | |
DE50203788D1 (de) | Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
BRPI0408655A (pt) | formulações compreendendo um agente ativo e cacau em pó e a sua utilização | |
DE60134274D1 (en) | Complex enthaltend modafinil und cyclodextrin | |
BR0012696A (pt) | Composição oftálmica | |
BR0208727A (pt) | Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia | |
WO2008105808A3 (en) | FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES | |
BR0011064A (pt) | Processo para a preparação de um poliol, e, composição de poliol | |
ES2170143T3 (es) | Composiciones que comprenden halofantrina en una forma especial. | |
BR0309113A (pt) | Composições farmacêuticas de liberação controlada de carbidopa e levodopa e processo para a preparação das mesmas | |
AR047480A1 (es) | Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion | |
AU4789099A (en) | Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
BR0009194A (pt) | Composição do resorcinol | |
AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
BR0210063A (pt) | Composição estável e uso da mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: B82Y 5/00 (2011.01), A61K 31/565 (2006.0 |